Physician profile
Carmen C Mcgee
NPI 1851421606
$1,215.74
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $24.58 · 2021: $66.87 · 2023: $412 · 2024: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $590 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.59 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $259.00 | 2019-2023 | |
| Astellas Pharma US INC | $248.73 | 2019-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $106.39 | 2019-2024 | |
| Therapeuticsmd, INC. | $88.11 | 2019 | |
| Mayne Pharma Commercial LLC | $65.34 | 2023 | |
| Sumitomo Pharma America, INC. | $47.95 | 2023 | Myfembree |
| Medtronic, INC. | $45.48 | 2024 | Ligasure |
| Mycovia Pharmaceuticals, INC. | $39.38 | 2023 | Vivjoa |
| Ethicon US, LLC | $37.91 | 2019 | |
| Lupin INC. | $34.99 | 2019 | |
| Allergan, INC. | $27.75 | 2019 | |
| Pfizer INC. | $24.98 | 2024 | |
| Exeltis, USA INC. | $23.66 | 2023 | Slynd |
| Amgen INC. | $21.37 | 2019 | |
| Shield Therapeutics INC | $18.94 | 2023 | Accrufer |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $18.77 | 2023 | Nexplanon |
| Coopersurgical, INC. | $18.24 | 2023 | Endosee |
| Hologic Sales and Service, LLC | $18.04 | 2023 | Myosure Tissue Removal Device, Coolseal Generator |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Daiichi Sankyo INC. | $16.09 | 2023 | Injectafer |
| Mylan Pharmaceuticals INC. | $14.24 | 2019 | |
| Mission Pharmacal Company | $12.67 | 2024 | Uribel Tabs |
| Amag Pharmaceuticals, INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmen Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.